EW

Edwards Lifesciences Corp

(RTTNews) - Edwards Lifesciences Corporation (EW) said that it has appointed Theodora Mistras as chief financial officer effective at the end of May...

Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) VP Daniel Lippis sold 1,019 shares of Edwards Lifesciences stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $83.01, for a total value of $84,587.19. Following the completion of the sale...

Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (Doretta) Mistras as the companys corporate vice president and chief financial officer (CFO), effective at the end of May...

PFA Pension Forsikringsaktieselskab acquired a new position in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) in the fourth quarter, according to its most recent Form 13F filing...

M&T Bank Corp lessened its holdings in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 78.8% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,277 shares of the medical research company's stock after sellin...

Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The...

US Bancorp DE reduced its holdings in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 4.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 363,376 shares of the medical research company's stock afte...

Kornitzer Capital Management Inc. KS cut its stake in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 18.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,560 shares of the medical...

New York State Teachers Retirement System decreased its position in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 424,311 shares of the medical...